| UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
| | OMB APPROVAL | | OMB Number: | 3235-0080 | | Expires: | February 28, 2009 | | Estimated average burden | | hours per response: | 1.7 |
|
|
| Commission File Number | 001-31822 |
| |
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
| | Address: | 3950 S. Country Club Road | | | Tucson | ARIZONA | 85714 | | | Telephone number: | 520-365-3100 |
| |
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
| | Common Stock | |
(Description of class of securities)
|
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
| ☐
17 CFR 240.12d2-2(a)(1)
| | ☐17 CFR 240.12d2-2(a)(2)
| | ☐17 CFR 240.12d2-2(a)(3)
| | ☐17 CFR 240.12d2-2(a)(4)
| | ☒
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1 | | ☐
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
|
|
Pursuant to the requirements fo the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
| 2025-07-21 | By | Aravind Menon | | Hearings Advisor | | Date | | Name | Title |
|
| 1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
|
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
|
Delisting Determination, The Nasdaq Stock Market, LLC, July 11, 2025,
Accelerate Diagnostics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Accelerate Diagnostics, Inc.
effective at the opening of the trading session on July 31, 2025.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on May 8, 2025.
The Company did not file an appeal.
The Company common stock was suspended on May 15, 2025.
The Staff determination to delist the Company common
stock became final on May 15, 2025.